PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Carbon-based stimuli-responsive nanomaterials: classification and application

Carbon-based stimuli-responsive nanomaterials: classification and application
2023-06-03
(Press-News.org)

Carbon-based stimuli-responsive nanomaterials are gaining much attention due to their versatility, including disease diagnosis and treatment. They work under endogenous (pH, temperature, enzyme, and redox) or exogenous (temperature, light, magnetic field, ultrasound) stimuli. Carbon-based stimuli-responsive nanomaterials can be used as smart materials with dynamically tunable physicochemical properties in response to changes in internal or external environmental stimuli. Their diverse combinations of nanostructures and molecular designs, as well as functional complexes with different carriers, create new opportunities for the development of advanced smart nanomaterials.

 

A research team from the Beijing Institute of Technology review the classification and application of carbon-based stimuli-responsive nanomaterials, based on their microstructures and properties, and discuss the applications of carbon-based stimuli-responsive nanomaterials in probes, bioimaging, tumor therapy, and other fields. Finally, they analyze and summarize the advantages and disadvantages of carbon-based stimuli-responsive nanomaterials and provide an outlook on their application prospects.

 

They published their recommendations in Cyborg and Bionic Systems, on Mar 9.

 

The authors classify carbon-based nanomaterials into 3 main categories: carbon nanotubes, carbon nanospheres, and carbon nanofibers. At the same time, several carbon-based stimuli-responsive nanomaterials involved in the research at the frontier of science and engineering are listed, and more specific differences are reflected in the synthesis and preparation methods of various carbon nanomaterials.

 

Then, the authors list the applications of carbon-based stimuli-responsive materials in the field of probes, bioimaging, and tumor therapy. Carbon-based nanomaterials are used in anti-counterfeiting and optical imaging applications due to their unique optical properties. Conjugation with different targeted detection reagents can increase the sensitivity of carbon-based nanomaterials. Carbon-based nanomaterials can also be used as drug delivery carriers or therapeutic reagents (photothermal, photodynamic, chemotherapy, etc.) for disease treatment.

 

Finally, the authors discuss the limitations of the development of carbon-based stimuli-responsive materials and the future perspective. Carbon-based stimuli-responsive materials not only have excellent physical and chemical properties, but also can be combined with other polymers for functionalization, and become excellent carriers for drug delivery and cancer treatment. At present, the safety of carbon-based stimuli-responsive materials is unknown because of the lack of key evidence in medical clinical experiments. To better reduce the controversy of carbon-based stimuli-responsive materials and increase credibility, it is necessary to conduct in-depth research on toxicology, pathology, and biodynamics.

 

This review summarizes the classification of carbon-based stimuli-responsive materials and their application in the field of biology and chemistry, and discusses the existing defects and future development of them. In general, many studies have shown that carbon-based stimuli-responsive materials play an important role in the biomedical field through hybridization. However, to better reduce the controversy of them and improve their credibility, it is necessary to conduct in-depth research on toxicology and pathology. In the future, researchers are expected to develop new synthetic methods or create new composite materials to improve the safety of carbon-based stimuli-responsive materials and make them more beneficial to human life.

END


[Attachments] See images for this press release:
Carbon-based stimuli-responsive nanomaterials: classification and application

ELSE PRESS RELEASES FROM THIS DATE:

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer
2023-06-03
ABSTRACT: 4008 CHICAGO ― HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory HER2-positive biliary tract cancer (BTC), researchers from The University of Texas MD Anderson Cancer Center reported at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. The study results also were published today in The Lancet Oncology. In the first cohort of the global Phase II HERIZON-BTC-01 trial, which included 80 patients with HER2-positive tumors, the confirmed objective response rate (cORR) was 41% with a median duration of response (DOR) of 12.9 months at a median follow-up of 12.4 months. ...

Children with drug-resistant epilepsy live longer after cranial surgery

2023-06-03
Survival rate beyond 10 years in children with drug-resistant epilepsy (DRE) was highest after cranial epilepsy surgery and lowest when treated only with antiseizure medications, according to a study published in The Lancet Child and Adolescent Health. This large, retrospective study was the first to compare long-term survival in children with DRE among cohorts treated with medications only, vagus nerve stimulation plus medications, and cranial epilepsy surgery plus medications. Results show that risk of early death was reduced by over 80 percent after surgery and by 40 percent after ...

Can movie reviews predict box office success?

2023-06-03
When one thinks of movie reviews, one might see them as harbingers of success or failure at the box office. Some researchers have previously found that both positive and negative reviews correlate to box office revenues, and the effect of negative reviews diminishes over time. However, researchers at the University of California, Davis, suggest that is not the case. Researchers analyzed pre-release commentary and opening weekend box office revenue, turning  the impact of movie reviews on its head and revealing an unexpected harbinger of failure phenomenon in the movie industry.  The study, ...

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
2023-06-03
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely to cause serious disease or prove fatal. Bile duct cancers affect the biliary tract, which consists of organs and ducts that make and store bile and release it into the small intestine. They are known as “silent” cancers, because there are usually no symptoms until they reach later stages. Surgery can be effective if bile duct cancer is caught early, ...

Startups to unveil cutting-edge point-of-care technologies at Boston medtech event

Startups to unveil cutting-edge point-of-care technologies at Boston medtech event
2023-06-02
June 2, 2023   Contact: Emily Gowdey-Backus, 978-934-3369 or Emily_GowdeyBackus@uml.edu Nancy Cicco, 978-934-4944 or Nancy_Cicco@uml.edu   Startups to unveil cutting-edge point-of-care technologies at Boston medtech event   Medtech and life sciences entrepreneurs and investors forging the future of health care will come together Tuesday, June 6, to showcase pioneering technologies and grow the region’s medtech ecosystem.   The 2023 Point of Care Showcase and Pitch Event will be a free, in-person program beginning at 2 p.m. at Mintz, 1 Financial Center, 40th Floor, Boston, to introduce ...

Weigh a quasar’s galaxy with precision

Weigh a quasar’s galaxy with precision
2023-06-02
A team of researchers from EPFL have found a way to use the phenomenon of strong gravitational lensing to determine with precision – about 3 times more precise than any other technique – the mass of a galaxy containing a quasar, as well as their evolution in cosmic time. Knowing the mass of quasar host galaxies provides insight into the evolution of galaxies in the early universe, for building scenarios of galaxy formation and black hole development. The results are published in Nature ...

Genetic variants may affect treatment response to commonly prescribed type 2 diabetes medication

2023-06-02
BOSTON – Various medications can be prescribed to lower blood sugar levels in individuals at high risk for developing type 2 diabetes, but it’s often unclear which patients will benefit most from which drugs. In a study published in Diabetologia, investigators at Massachusetts General Hospital (MGH), founding member of Mass General Brigham (MGB), identified genetic variants associated with response to two such drugs: metformin and glipizide. The findings may help personalize ...

UC Davis C-STEM trains Redlands teachers on bringing computer science into math

UC Davis C-STEM trains Redlands teachers on bringing computer science into math
2023-06-02
Twenty-five teachers from Redlands Unified School District in southern California recently completed training in integrating computer science into math education through a joint program offered by the University of California, Davis, and UC Riverside Extension. The Joint Computer Science Supplementary Teaching Credential Authorization Program has helped Redlands address gaps in student opportunity and achievement, and teachers’ skills. “Improving math instruction for student success is the most challenging task in education. Redlands partnered with UC Davis to make math instruction with ...

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

2023-06-02
The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories (complete or partial response, or stable or progressive disease) based on the percent of change in the sum of the longest diameters of a set of target lesions.  An analysis of data from the SWOG S1609 trial conducted by the NCI-funded National Clinical Trials Network (NCTN) finds that in patients treated with immune checkpoint inhibitors, survival times correlate linearly with that change, rather than exhibiting threshold effects ...

Bench-to-field study identifies pesticides that could influence Parkinson's disease

2023-06-02
A new study from researchers in the Khurana lab at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in close collaboration with researchers from the Ritz lab at UCLA and the Rubin lab at Harvard University, identified pesticides that could be relevant to the development of Parkinson’s disease. The study was led by Richard Krolewski, MD, PhD, a neurologist in the Brigham’s Division of Movement Disorders and Ann Romney Center for Neurologic Diseases, and Kimberly ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Carbon-based stimuli-responsive nanomaterials: classification and application